Inhibition of Melanoma Cell Growth by Salvianolic Acid A through CHK2-CDC25A Pathway Modulation
Open Access
- 12 June 2024
- journal article
- research article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 29 (6) , 213
Abstract
Background: This study investigated the impact of salvianolic acids, derived from Danshen, on melanoma cell growth. Specifically, we assessed the ability of salvianolic acid A (Sal A) to modulate melanoma cell proliferation. Methods: We used human melanoma A2058 and A375 cell lines to investigate the effects of Sal A on cell proliferation and death by measuring bromodeoxyuridine incorporation and lactate dehydrogenase release. We assessed cell viability and cycle progression using water soluble tetrazolium salt-1 (WST-1) mitochondrial staining and propidium iodide. Additionally, we used a phospho-kinase array to investigate intracellular kinase phosphorylation, specifically measuring the influence of Sal A on checkpoint kinase-2 (Chk-2) via western blot analysis. Results: Sal A inhibited the growth of A2058 and A375 cells dose-responsively and induced cell cycle arrest at the G2/M phase. Notably, Sal A selectively induces Chk-2 phosphorylation without affecting Chk-1, thereby degrading Chk-2-regulated genes Cdc25A and Cdc2. However, Sal A does not affect the Chk1-Cdc25C pathway. Conclusions: Salvianolic acids, especially Sal A, effectively hinder melanoma cell growth by inducing Chk-2 phosphorylation and disrupting G2/M checkpoint regulation.Keywords
Funding Information
- Startup Fund for Scientific Research of Fujian Medical University (2020QH1112)
This publication has 37 references indexed in Scilit:
- Oncogenic BRAF induces whole-genome doubling through suppression of cytokinesisNature Communications, 2022
- A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistanceNature Immunology, 2022
- Sodium Danshensu inhibits the progression of lung cancer by regulating PI3K/Akt signaling pathwayDrug Development Research, 2021
- Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseasesBiomedicine & Pharmacotherapy, 2020
- Antimetastatic potentials of salvianolic acid A on oral squamous cell carcinoma by targeting MMP‐2 and the c‐Raf/MEK/ERK pathwayEnvironmental Toxicology, 2018
- The Anticancer Properties of Salvia Miltiorrhiza Bunge (Danshen): A Systematic ReviewMedicinal Research Reviews, 2013
- Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasionEuropean Journal of Pharmacology, 2010
- Effect of sodium caprate on the oral absorptions of danshensu and salvianolic acid BInternational Journal of Pharmaceutics, 2009
- Defective Cell Cycle Checkpoint Functions in Melanoma Are Associated with Altered Patterns of Gene ExpressionJournal of Investigative Dermatology, 2008
- Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanismThe EMBO Journal, 2004